SEC Filing Details
Document Details
Form
Filing Date
Jan 17, 2019
Document Date
Jan 17, 2019
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Akero Therapeutics, Inc.
Issuer
Akero Therapeutics, Inc.